Cross-over Study of Coronary Risk Factors With a Polypill

NCT05030818 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Polypill of acetylsalicylic acid, ramipril and atorvastatin
DRUG: Drugs taken separately: acetylsalicylic acid, ramipril and atorvastatin

Sponsor

Fundación EPIC